At this week's Society of Breast Imaging (SBI) meeting in Austin, TX, brachytherapy firm Cianna Medical is touting the results of a clinical trial to evaluate its SAVI Scout surgical guidance system for localizing and directing the removal of nonpalpable breast lesions.
Results from a trial of 154 patients demonstrated a 100% surgical success rate using the device, with a low re-excision rate that is in line with rates reported for intraoperative ultrasound, the company said. The study was conducted at 11 sites, with 17 surgeons and 24 radiologists contributing, according to Cianna.
The group also investigated clinician and patient satisfaction with SAVI Scout. On a scale of 1 to 5, surgeons rated the device's ease of localization at 3.9 and the ability to start cases earlier at 4.9. Postprocedural survey data showed that 97% of patients would recommend the procedure to other patients.
